OmniAb, Inc. (OABI)
NASDAQ·Healthcare·Biotechnology
$2.00
-0.99%
Mkt Cap $251.28M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+100.0%
Consensus $4.00 vs current $2.00
NASDAQ·Healthcare·Biotechnology
$2.00
-0.99%
Mkt Cap $251.28M
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
+100.0%
Consensus $4.00 vs current $2.00